[go: up one dir, main page]

PT79840A - Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith - Google Patents

Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith

Info

Publication number
PT79840A
PT79840A PT79840A PT7984085A PT79840A PT 79840 A PT79840 A PT 79840A PT 79840 A PT79840 A PT 79840A PT 7984085 A PT7984085 A PT 7984085A PT 79840 A PT79840 A PT 79840A
Authority
PT
Portugal
Prior art keywords
alpha
preparation
amilase
polipeptides
pharmaceutical compositions
Prior art date
Application number
PT79840A
Other languages
English (en)
Other versions
PT79840B (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT79840A publication Critical patent/PT79840A/pt
Publication of PT79840B publication Critical patent/PT79840B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT79840A 1984-01-21 1985-01-18 Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith PT79840B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3402021 1984-01-21

Publications (2)

Publication Number Publication Date
PT79840A true PT79840A (en) 1985-02-01
PT79840B PT79840B (en) 1986-11-14

Family

ID=6225535

Family Applications (1)

Application Number Title Priority Date Filing Date
PT79840A PT79840B (en) 1984-01-21 1985-01-18 Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith

Country Status (17)

Country Link
US (1) US4623714A (pt)
EP (1) EP0151246B1 (pt)
JP (1) JPS60152500A (pt)
KR (1) KR850005454A (pt)
AT (1) ATE56728T1 (pt)
AU (1) AU580973B2 (pt)
CA (1) CA1230841A (pt)
DE (1) DE3483260D1 (pt)
DK (1) DK520784A (pt)
ES (1) ES8602112A1 (pt)
FI (1) FI844289L (pt)
GR (1) GR80840B (pt)
HU (1) HU192495B (pt)
IL (1) IL73472A0 (pt)
NO (1) NO844422L (pt)
PT (1) PT79840B (pt)
ZA (1) ZA848651B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508384A1 (de) * 1985-03-08 1986-11-06 Boehringer Mannheim Gmbh, 6800 Mannheim Hemmung humaner speichel- und pankreasamylase durch monoklonale antikoerper
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
US7829552B2 (en) 2003-11-19 2010-11-09 Metabasis Therapeutics, Inc. Phosphorus-containing thyromimetics
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
EP2571860A1 (en) 2010-05-21 2013-03-27 Pfizer Inc 2-phenyl benzoylamides
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828343A1 (en) 2011-03-04 2012-09-13 The Scripps Research Institute Edn3-like peptides and uses thereof
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
RU2618628C1 (ru) 2013-04-17 2017-05-05 Пфайзер Инк. Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
AU2015308350B2 (en) 2014-08-29 2020-03-05 Tes Pharma S.R.L. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
KR20190065312A (ko) 2016-10-14 2019-06-11 테스 파마 에스.알.엘. 알파-아미노-베타-카복시뮤콘산 세미알데하이드 데카복실라제의 저해제
AU2019385644A1 (en) 2018-11-20 2021-06-03 Tes Pharma S.R.L. Inhibitors of α-Amino-β-carboxymuconic acid semialdehyde decarboxylase
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof
CN119285700A (zh) * 2024-12-12 2025-01-10 青岛农业大学 具有抗氧化降血糖功效的小分子活性肽、组合物和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2716050A1 (de) * 1977-04-09 1978-10-19 Hoechst Ag Alpha-amylase-inhibitor aus einem streptomyceten und verfahren zu seiner gewinnung
ES505959A0 (es) * 1980-10-09 1982-09-01 Hoechst Ag Procedimiento para la preparacion de un inactivador de alfa-amilasa

Also Published As

Publication number Publication date
NO844422L (no) 1985-07-22
ATE56728T1 (de) 1990-10-15
DK520784A (da) 1985-07-22
FI844289A0 (fi) 1984-11-01
FI844289L (fi) 1985-07-22
ES539678A0 (es) 1985-11-16
EP0151246B1 (de) 1990-09-19
ZA848651B (en) 1985-06-26
KR850005454A (ko) 1985-08-26
EP0151246A2 (de) 1985-08-14
DE3483260D1 (de) 1990-10-25
ES8602112A1 (es) 1985-11-16
EP0151246A3 (en) 1987-05-27
IL73472A0 (en) 1985-02-28
DK520784D0 (da) 1984-11-01
AU580973B2 (en) 1989-02-09
HU192495B (en) 1987-06-29
AU3519084A (en) 1985-07-25
PT79840B (en) 1986-11-14
GR80840B (en) 1985-02-26
JPS60152500A (ja) 1985-08-10
US4623714A (en) 1986-11-18
CA1230841A (en) 1987-12-29
HUT37657A (en) 1986-01-23

Similar Documents

Publication Publication Date Title
PT79840B (en) Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith
IL76457A (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
IL76454A0 (en) Diarylacetylenes,their preparation and pharmaceutical compositions containing them
DE3366141D1 (en) 1-phenylisoquinoline derivatives, process for their preparation, pharmaceutical compositions containing these compounds and their use
ZA832135B (en) Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof
DE3370482D1 (en) Substituted 8-phenylxanthines
ES8707732A1 (es) Procedimiento para preparar 1,2,4 triazolo 1,5-c quinazolinas
ES8403910A1 (es) Procedimiento para la preparacion de nitratos de amino-deso-xi-1.4;3.6-dianhidro-hexito,asi como de sus sales de adicionacida farmacologicamente inocuas
DE3063905D1 (en) Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them
ES8105991A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
AU539847B2 (en) 3,4,5-trihydroxypiperidine compounds
IL60323A0 (en) Pseudotrisaccharide compounds,their preparation and their medicinal use
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
ES8600758A1 (es) Procedimiento para preparar derivados de1,3-dioxolanilo
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
EP0301371A3 (en) Benzofuran carboxamides with basic substituents, process for their preparation and therapeutical compositions containing them
GR3015706T3 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
GR3001809T3 (en) Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments